REFERENCES
- Higgs DR, Weatherall DJ. The Haemoglobinopathies, Vol. 6(1). London: Bailliere's Clin. Haematol. 1993.
- van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld CL, Giordano PC. Evaluating five dedicated automatic devices for haemoglobinopathy diagnostics in multi-ethnic populations. Int J Lab Hematol. 2009 31(5):484–495.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
- Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of α-thalassaemia deletions and α-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108:295–299.
- Giordano PC, Maatman RG, Niessen RW, van Delft P, Harteveld CL. β Thalassemia IVS-I-5 (G→C) heterozygosity masked by the presence of Hb J-Meerut in a Dutch-Indian patient. Haematologica. 2006;91(12 Suppl):ECR56.
- Daar S, Hussain HM, Merghoub T, Krishnamoorthy R. 1998. Spectrum of β-thalassemia mutations in Oman. Ann N Y Acad Sci. 1998;850:404–406.
- Amato A, Grisanti P, Lerone M, Ponzini D, Di Biagio P, Cappabianca MP, Giordano PC. Prevention strategies for severe hemoglobinopathies in endemic and nonendemic immigration countries: the Latium example. Prenat Diagn. 2009;29(12)1171–1174.
- Gonzalez-Redondo JM, Stoming TA, Kutlar F, Kutlar A, Hu H, Wilson JB, Huisman THJ. 1989. HB Monroe or α2β230(B12)Arg→Thr, a variant associated with β-thalassemia due to a G→C substitution adjacent to the donor splice site of the first intron. Hemoglobin. 1989;13(1):67–74.
- Sweeting I, Serjeant BE, Serjeant GR, Kulozik AE, Vetter B. Hb S-Hb Monroe; a sickle cell-β-thalassemia syndrome. Hemoglobin. 1998;22(2):153–156.
- El-Kalla S, Mathews AR. A significant β-thalassemia heterogeneity in the United Arab Emirates. Hemoglobin. 1997;21(3):237–247.
- Ganeshaguru K, Acquaye JK, Samuel AP, Hassounah F, Agyeiobese S, Azrai LM, Sejeny SA, Omer A. Prevalence of thalassaemias in ethnic Saudi Arabians. Trop Geogr Med. 1987;39(3):238–243.